Samceda innovation award winners unveiled
Achaogen receives award in 'Biotech/Healthcare Innovator' category of San Mateo Economic Development Corporation 'Innovators: 2012 Awards of Excellence' contest.
San Francisco Business Times
February 28, 2012
[ more Achaogen news ]
Scientific & General Publications/Posters
A double-blind, randomized, placebo-controlled study to assess the safety, tolerability, plasma pharmacokinetics and lung penetration of intravenous plazomicin in healthy subjects
Robert Cass, Corwin F Kostrub, Mark Gotfried, Keith Rodvold, Kenneth J Tack, Jon Bruss
Achaogen Inc., South San Francisco, CA, Pulmonary Associates, Phoenix, AZ, University of Illinois, Chicago, IL, Medpace Inc., Cincinnati, OH.
ECCMID 2013, poster # P-1637
The pharmacokinetics (PK) and safety of plazomicin in subjects with renal impairment
V. Riddle, D. Cebrik, C. Kostrub, L. Ma, Scott A. Van Wart, K. J. Hillan
BioPharmAdvisors LLC, Crofton, MD, USA; AxiStat, Inc., San Francisco, CA, USA; Achaogen, Inc., S. San Francisco, CA, USA; Institute for Clinical Pharmacodynamics, Latham, NY, USA
ECCMID 2013, poster # P-918
Plazomicin demonstrates potent efficacy against carbapenem-resistant enterobacteriaceae (CRE) in the neutropenic mouse thigh infection model
Arnold Louie, Corwin F. Kostrub, Steve Fikes, Weiguo Liu, Lee Ann Feeney, Lynn Connolly, George Drusano
Inst. For Therapeutic Innovation, Univ. of Florida, Orlando, FL; Achaogen, Inc., South San Francisco, CA
ECCMID 2013, poster # LB 2961
[ more posters / scientific publications ]
Bacterial Resistance in the News
‘We Have a Limited Window of Opportunity’: CDC Warns of Resistance ‘Nightmare’
'It’s not often that you get to hear a top federal health official deliberately deploy a headline-grabbing word such as “nightmare,” or warn: “We have a very serious problem, and we need to sound an alarm.” | Dr. Thomas Frieden, director of the US Centers for Disease Control and Prevention, said both Tuesday, during a press conference announcing new CDC statistics on the advance of the highly drug-resistant bacteria known as CRE."'
Mar 6, 2013
Antibiotic-Resistant Bacteria Found in 37 U.S. States
"In at least 37 states, Washington, D.C., and Puerto Rico, doctors have identified bacteria, including E. coli, that produce Klebsiella pneumoniae carbapenemase, or KPC--an enzyme that makes bacteria resistant to most known treatments."
Yahoo News / U.S.News & World Report
Jan 31, 2012
[ more bacterial resistance in the news ]